|
a phase 3, international, randomised, double-blind, placebo-controlled study to evaluate the effect of sodium zirconium cyclosilicate on chronic kidney disease (ckd) progression in participants with ckd and hyperkalaemia or at risk of hyperkalaemia
|
19-01-202318-05-2026
|
Penyelidik Bersama
|
|
prevalence and associated factors of mild cognitive impairment and dementia in chronic kidney disease patients
|
16-05-202416-11-2025
|
Penyelidik Bersama
|
|
treatment of cardiovascular disease with low dose rivaroxaban in advanced chronic kidney disease (track)
|
10-10-202009-10-2025
|
Ketua Projek
|
|
the economic consequences of acute kidney injury in intensive care units at a tertiary centre in malaysia: a prospective cost-effectiveness analysis
|
31-07-202330-07-2024
|
Penyelidik Bersama
|
|
the prevalence of intradialytic hypertension and its association with global longitudinal strain assessment.
|
25-03-202124-03-2024
|
Penyelidik Bersama
|
|
a phase 2b randomised, double-blind, placebo-controlled, multi-centre, dose-ranging study of azd5718 in participants with proteinuric chronic kidney disease
|
24-01-202123-01-2024
|
Penyelidik Bersama
|
|
randomised, double-blind, placebo-controlled and parallel dose group trial to investigate efficacy and safety of multiple doses of oral bi 690517 over 14 weeks, alone and in combination with empagliflozin, in patients with diabetic and non-diabetic chroni
|
28-02-202227-10-2023
|
Penyelidik Bersama
|
|
height adjusted total kidney volume (httkv) using mri and age at httkv0 in predicting decline of renal function in malaysian autosomal dominant polycystic kidney disease (adpkd) cohort.
|
17-12-202016-12-2022
|
Penyelidik Bersama
|